GlobeNewswire

Barloworld Equipment Innovates its Service with Librestream's Onsight

Dela

Librestream's Onsight platform brings expert remote capability to Barloworld Equipment

WINNIPEG, Manitoba, July 25, 2018 (GLOBE NEWSWIRE) -- Barloworld Equipment, southern Africa's leading Caterpillar dealer, has a reputation for excellence. The company is relentless in pursuit of its mission to deliver innovative solutions for exceptional customer performance through its people. To this end, Barloworld Equipment recently invested in Librestream's remote expert solution, Onsight. The solution will enable its field technicians to connect to remote expertise from any location and capture content for mentoring and later use. It will also provide technicians a safer way to perform inspections in the typically difficult field environments in which they operate.

"It was important to us to find an expert remote solution that provides the stability we need in the field while allowing our workforce to easily communicate cross-border. Not only will Onsight provide our teams with live remote mentoring, but also a way to quickly and efficiently get their job done for customers," said Barloworld Equipment's Charl Groenewald, Executive Head: Customer Fulfillment Services.

Barloworld Equipment is equipping its service teams with the Onsight Connect expert remote software as well as the Onsight rugged hardware products. A selection of these will be applied to the different service environments that teams typically operate in:

  • Onsight Cube , used for inspections at height or under vehicles, avoids field technicians moving into hazardous situations. Its thermal imaging capability also enables data collection on temperatures - mining equipment exhausts being an example.
  • Onsight Smartcam will have application in workshop situations, measuring and inspecting cracks or defects in equipment.
  • Onsight Hub, used exclusively with a field technician's borescope, assists with both inspections as well as mentoring of new technicians on the use of this equipment.

"Onsight is designed to empower workers by connecting them to their teams and the content they need to access," Kerry Thacher, CEO at Librestream said. "We are excited to be a part of Barloworld Equipment's innovative approach to enhance its customers' expectations and services."

About Barloworld Equipment
Barloworld Equipment is a division of Barloworld Limited, a multinational brand distribution company listed on the Johannesburg Stock Exchange.

Barloworld Equipment is the dealer for Cat earthmoving machines and Cat power systems in all its southern African territories - South Africa, Lesotho, Swaziland, Namibia, Botswana, Angola, Malawi, Mozambique, Zambia and the Democratic Republic of Congo's Katanga Province (in joint venture with Tractafric Equipment).

Additionally, Barloworld Equipment is the Cat dealer for Siberia and the Russian Far East.

Barloworld Equipment also operates in the United Kingdom and China.

Other Barloworld Group divisions comprise Barloworld Automotive and Barloworld Logistics.

Find more at www.barloworld-equipment.com and connect with us on LinkedInFacebook & Twitter.

About Librestream Technologies Inc.
Librestream develops digital transformation technology that improves service operations within the industrial sector. Deployed globally, the Onsight augmented reality service platform empowers workers to rapidly diagnose, inspect, and manage assets in even the most difficult field environments. The Onsight platform includes core AR capabilities including remote expert, digital work instructions and rich content access. Visit Librestream at www.librestream.com and connect with us on LinkedInFacebook & Twitter.

CONTACT INFORMATION

Press Contact:

Jacqui Janse van Rensburg
Communications Manager
Barloworld Equipment southern Africa
Tel: 011 301 4000
Email: JVRensburg1@barloworld-equipment.com

Marieke Wijtkamp
Vice President of Marketing & Client Services
Librestream Technologies Inc.
Tel: 204.487.0612 ext. 259
Email: marieke.wijtkamp@librestream.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fc0d5439-e2d2-4c25-af87-5cecf99a5812




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Librestream Technologies Inc. via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum